When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MYOK - MyoKardia to launch new study of mavacamtem
MyoKardia Inc.
MyoKardia (MYOK-1.2%) plans to launch a study in H1 2020 evaluating lead drug mavacamten as an alternative to septal reduction therapy (SRT) in patients with obstructive hypertrophic cardiomyopathy (HCM), a disorder in which the heart muscle becomes abnormally thick making it harder for the heart to pump blood.
More news on: MyoKardia, Inc., Healthcare stocks news,